Card Tech Minutes 2017.10.11-13: Difference between revisions
Jump to navigation
Jump to search
| Line 19: | Line 19: | ||
:'''CPN Extensions - Charles Thomas''' | :'''CPN Extensions - Charles Thomas''' | ||
:Review of possible additions to the CPN including: indications, disease states, and clinical per-procedure evaluation, e.g. CHADS-2 Vasc score. The challenge is ''how do you code a process?'' We may create a checkbox, along the lines of ''was this process completed?'' There may be difficulties with documenting how an Acceptable Use Criteria or Clinical Decision Support tool was used. | :Review of possible additions to the CPN including: indications, disease states, and clinical per-procedure evaluation, e.g. CHADS-2 Vasc score. The challenge is ''how do you code a process?'' We may create a checkbox, along the lines of ''was this process completed?'' There may be difficulties with documenting how an Acceptable Use Criteria or Clinical Decision Support tool was used. | ||
:There are gaps in the underlying specifications for the LAAO Registry regarding data dictionaries, for aborting a procedure, as well other items for deploying devices | :There are gaps in the underlying specifications for the LAAO Registry regarding data dictionaries, for aborting a procedure, as well other items for deploying devices. There are some issues that need to be resolved and include normative vs. extensible value sets. | ||
:'''CPN Companion Guide - Rebecca Baker''' | |||
:Text | |||
Revision as of 13:49, 11 December 2017
Attendees
- Chris Melo, Co-Chair, Philips Healthcare
- Nick Gawrit, Co-Chair, heartbase
- Paul Dow, Secretary, ACC
- Rebecca Baker, ACC
- Nakano Shinichi, Toshiba, IHE Japan
- Takeshi Oozeki, Toshiba, IHE Japan
- Ann Pollard, HCA
- Sophia Chaidez, HCA
- Dan Murphy, Epic
- Charles Thomas, University of Washington
- Birgit Roy, ACC
- Andrea Price, Indiana University
Minutes
- Planning Committee Discussion
- General discussion regarding the IHE process.
- What do we want to achieve with
- CPN Extensions - Charles Thomas
- Review of possible additions to the CPN including: indications, disease states, and clinical per-procedure evaluation, e.g. CHADS-2 Vasc score. The challenge is how do you code a process? We may create a checkbox, along the lines of was this process completed? There may be difficulties with documenting how an Acceptable Use Criteria or Clinical Decision Support tool was used.
- There are gaps in the underlying specifications for the LAAO Registry regarding data dictionaries, for aborting a procedure, as well other items for deploying devices. There are some issues that need to be resolved and include normative vs. extensible value sets.
- CPN Companion Guide - Rebecca Baker
- Text